Evidence map›Paper›PMID 41989963›Full record

ArticleJMIR formative research2026

Artificial Intelligence Design for Race-Based Prostate Cancer Stage Classification With Multilayer Perceptron: Feature Selection Optimization Approach.

Adithama Mulia, David Agustriawan, Marlinda Overbeek, Moeljono Widjaja, Vincent Kurniawan, Jheno Syechlo, Muhammad Imran Ahmad, Srinivasulu Yerukala Sathipati, Nilubon Kurubanjerdjit

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adithama MuliaDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0009-0005-6885-0575
David AgustriawanDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0000-0003-1185-1145
Marlinda OverbeekDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0000-0003-2590-843X
Moeljono WidjajaDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0000-0003-3002-7426
Vincent KurniawanDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0009-0004-1238-5232
Jheno SyechloDepartment of Informatics, Faculty of Engineering and Informatics, Universitas Multimedia Nusantara, A Bldg, 5th Fl, Tangerang, 15810, Indonesia, 62 87781535936.ORCID 0009-0001-5557-5085
Muhammad Imran AhmadFaculty of Intelligent Computing, Universiti Malaysia Perlis, Kampus Pauh Putra, Perlis, Malaysia.ORCID 0000-0002-9157-5998
Srinivasulu Yerukala SathipatiCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.ORCID 0000-0002-0613-1242
Nilubon KurubanjerdjitSchool of Applied Digital Technology, Mae Fah Luang University, Chiang Rai, Thailand.ORCID 0000-0002-3038-3837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate cancer progression exhibits significant variability influenced by biological and racial factors. DNA methylation profiling has shown potential in early cancer detection, but its integration with machine learning across racially diverse populations remains limited. Objective: This study aimed to develop a prostate cancer stage classifier for the majority White cohort using DNA methylation data and a multilayer perceptron (MLP) model in order to classify prostate cancer stages into early (stages I-II) and late (stages III-IV) stages and assess its performance when applied to other racial groups to highlight the need for race-specific models. Methods: Methylation and phenotype data from the TCGA-PRAD (The Cancer Genome Atlas Prostate Adenocarcinoma) dataset were processed using differentially methylated position (DMP) analysis to identify CpG sites correlated with cancer stages. These features were further refined through recursive feature elimination (RFE) and used to train MLP models. Shapley Additive Explanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME) were used to interpret the model and identify key DNA methylation features contributing to model predictions. Results: The best-performing model achieved 95% accuracy and up to 99% area under the curve on the majority race (White) training data using 90 selected features. However, performance declined sharply in racial minority groups, revealing the effects of sample imbalance and race-specific methylation patterns. Feature importance examination indicated strong patterns within certain CpG sites driving model predictions. Conclusions: We propose a race-aware MLP model for prostate cancer stage classification using DNA methylation data, which has been optimized through DMP and RFE-based feature selection. SHAP and LIME confirmed the predictive relevance of selected CpG sites, supporting model transparency. The results highlight high performance within the White cohort but reveal poor generalization to racial minority groups, emphasizing the importance of race-specific modeling strategies.

Indexed as

Artificial IntelligenceNeoplasm StagingProstatic NeoplasmsClassification AlgorithmsDNA MethylationHumansMaleMultilayer PerceptronsWhitedifferentially methylated positionsDNA methylationexplainable artificial intelligencefeature selectionmultilayer perceptronprostate cancerrace-aware model

Identifiers

PMID41989963
PMCPMC13086062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.